» Articles » PMID: 37240876

Endotypes of Nasal Polyps in Children: A Multidisciplinary Approach

Overview
Journal J Pers Med
Date 2023 May 27
PMID 37240876
Authors
Affiliations
Soon will be listed here.
Abstract

Nasal polyps (NPs) are rarely reported in childhood and usually represent red flags for systemic diseases, such as cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and immunodeficiencies. The European Position Paper released in 2020 (EPOS 2020) provided a detailed classification and defined the correct diagnostic and therapeutic approaches. We report a one-year experience of a multidisciplinary team, made up of otorhinolaryngologists, allergists, pediatricians, pneumologists and geneticists, with the aim of ensuring a personalized diagnostic and therapeutic management of the pathology. In 16 months of activity, 53 patients were admitted (25 children with chronic rhinosinusitis with polyposis and 28 with antro-choanal polyp). All patients underwent phenotypic and endo-typic assessment, using proper classification tools for nasal pathology (both endoscopic and radiological), as well as adequate cytological definition. An immuno-allergic evaluation was carried out. Pneumologists evaluated any lower airway respiratory disease. Genetic investigations concluded the diagnostic investigation. Our experience enhanced the complexity of children's NPs. A multidisciplinary assessment is mandatory for a targeted diagnostic and therapeutic pathway.

Citing Articles

Clinical and Histological Differences Between Choanal Polyps in Children and Adults: A 15-Year Retrospective Study.

Peric A, Lazovic N, Sotirovic J, Barsova G, Vukomanovic durdevic B OTO Open. 2024; 8(4):e70004.

PMID: 39530085 PMC: 11551064. DOI: 10.1002/oto2.70004.


Unanswered questions on the use of biologics in pediatric asthma.

Nieto A, El-Sayed Z, Gomez R, Hossny E, Jiu-Yao W, Kalayci O World Allergy Organ J. 2023; 16(11):100837.

PMID: 38020283 PMC: 10656246. DOI: 10.1016/j.waojou.2023.100837.

References
1.
Schleimer R . Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol. 2016; 12:331-357. PMC: 5514544. DOI: 10.1146/annurev-pathol-052016-100401. View

2.
Ho J, Alvarado R, Rimmer J, Sewell W, Harvey R . Atopy in chronic rhinosinusitis: impact on quality of life outcomes. Int Forum Allergy Rhinol. 2019; 9(5):501-507. DOI: 10.1002/alr.22272. View

3.
De Corso E, Baroni S, Settimi S, Onori M, Mastrapasqua R, Troiani E . Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps. J Pers Med. 2022; 12(8). PMC: 9410079. DOI: 10.3390/jpm12081251. View

4.
De Marchi S, Cecchin E, De Marchi S, Iuri F, Sechi L . Risk of Chronic Rhinosinusitis With Nasal Polyps in Endotypes of Dermatophagoides pteronyssinus-Induced Rhinitis. J Allergy Clin Immunol Pract. 2022; 10(6):1506-1514.e2. DOI: 10.1016/j.jaip.2022.01.005. View

5.
Lund V, Kennedy D . Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997; 117(3 Pt 2):S35-40. DOI: 10.1016/S0194-59989770005-6. View